TSVT - 2seventy bio, Inc. Stock Price, Fair Value and News

$3.14+0.22 (+7.53%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TSVT Price Action

Last 7 days

-4.0%

Last 30 days

1.0%

Last 90 days

-37.8%

Trailing 12 Months

-18.4%

TSVT RSI Chart

TSVT Valuation

Market Cap

162.0M

Price/Earnings (Trailing)

-1.71

Price/Sales (Trailing)

3.55

EV/EBITDA

-1.19

Price/Free Cashflow

-1.15

TSVT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TSVT Fundamentals

TSVT Revenue

Revenue (TTM)

45.6M

Rev. Growth (Yr)

12.46%

Rev. Growth (Qtr)

50.93%

TSVT Earnings

Earnings (TTM)

-94.5M

Earnings Growth (Yr)

86.13%

Earnings Growth (Qtr)

-139.93%

TSVT Profitability

EBT Margin

-207.25%

Return on Equity

-41.45%

Return on Assets

-18.77%

Free Cashflow Yield

-86.99%

TSVT Investor Care

Shares Dilution (1Y)

1.90%

Diluted EPS (TTM)

-1.86

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	71.2M	44.1M	45.6M	0
2023	124.7M	147.3M	145.9M	100.4M
2022	51.0M	57.2M	51.4M	91.5M
2021	199.7M	151.3M	102.9M	54.5M
2020	0	0	146.2M	248.1M
2019	0	0	0	44.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About 2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

CEO	Mr. Nick Leschly
WEBSITE	2seventybio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	425

2seventy bio, Inc. Frequently Asked Questions

What is the ticker symbol for 2seventy bio, Inc.? What does TSVT stand for in stocks?

TSVT is the stock ticker symbol of 2seventy bio, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of 2seventy bio, Inc. (TSVT)?

As of Fri Dec 20 2024, market cap of 2seventy bio, Inc. is 161.99 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TSVT stock?

You can check TSVT's fair value in chart for subscribers.

Is 2seventy bio, Inc. a good stock to buy?

The fair value guage provides a quick view whether TSVT is over valued or under valued. Whether 2seventy bio, Inc. is cheap or expensive depends on the assumptions which impact 2seventy bio, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TSVT.

What is 2seventy bio, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, TSVT's PE ratio (Price to Earnings) is -1.71 and Price to Sales (PS) ratio is 3.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TSVT PE ratio will change depending on the future growth rate expectations of investors.